Background: The implementation of Human Papillomavirus based cervical screening continues apace on a global scale. Understanding the basis and burden of inadequate or invalid samples is important to ensure confidence in high quality laboratory results and inform the development of new technologies. Here we present population based data from Scotland and Denmark which detail the extent of invalid samples for HPV detection in both clinician-taken and self-taken samples. As a comparator we report on the rate of inadequate cytology preparations in both countries.
Methods: The proportion of samples with an invalid HPV test result was calculated by retrospective analysis of routine laboratory data associated with cervical screening programmes in the two countries. Two assays were in use for the programmes at the time (the Abbott RealTime High Risk HPV assay and the BD Onclarity); both have internal endogenous controls for human genes. In addition, acellular cytology samples were reported through a prospective audit (Scotland) and National quality reporting (Denmark).
Results: In total, 89,418 clinician samples and 14,677 self-taken samples were assessed. We observed low rates of invalid HPV tests in clinician taken samples (0.05-0.10 %), irrespective of sample collection media (ThinPrep or SurePath), HPV test system/endogenous control type or clinical indication for testing (primary screening, triage or test of cure). For self-taken samples, the number of invalid samples was 0.18 %. Complete absence of sample material (acellular) in clinician taken samples were observed at a level of 1 in approximately 16.5 thousand.
Conclusions: Clinician and self-taken samples appear robust specimens for HPV testing and acellular samples are very rare. Efforts to develop endogenous controls for HPV assays that provide greater insight into true sample adequacy for cervical disease detection, beyond measuring the presence of human cells, will be welcome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcv.2021.104756 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of time and temperature on the stability of HPV and cellular nucleic acid using simulated dry self-samples.
J Virol Methods
December 2024
Scottish HPV Reference Laboratory, NHS Lothian, Royal Infirmary of Edinburgh, Little France, Edinburgh EH16 4SA, United Kingdom; HPV Research Group, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom.
Background: Self-sampling is now a key component within HPV-based cervical screening programmes to engage individuals and enhance participation. As self-sampling is relatively new, information on the influence of pre-analytical parameters such as transit-temperature and time between sampling and testing on HPV test results requires detailed investigation.
Methods: FLOQSwabs® and Evalyn Brushes® were used to assess HPV and cellular stability over a 30-week period (0w,4w,12w,30w) at 4 °C, ambient, and 37 °C.
Young, deprived women are more at risk of testing positive for Chlamydia trachomatis: Results from a cross-sectional multicentre study in French health examination centres.
Public Health Pract (Oxf)
December 2024
Support and Education Technical Centre of Health Examination Centres (CETAF), Saint-Etienne, France.
Article Synopsis
- Chlamydia Trachomatis (CT) is the most common sexually transmitted infection in France, and this study evaluated the feasibility of systematic CT screening in Health Examination Centres (HECs) for young, sexually active individuals.
- A total of 1,701 eligible participants were offered screening, with a high acceptance rate of 90.1%; the overall prevalence of CT infection was found to be 4.7%, with higher rates among women (6.4%) compared to men (3.4%).
- The study revealed that deprivation significantly increased the likelihood of CT infection, particularly among women, highlighting the need to improve access to screening for disadvantaged populations to reduce health inequalities.
Implementation of home 'finger-prick' carcino-embryonic antigen testing for colorectal cancer follow-up - A pilot study of user acceptability.
Future Healthc J
March 2024
Consultant Colorectal Surgeon, Department of General Surgery, Brunel Building, Southmead Hospital, Southmead Road, Westbury-on-Trym, Bristol, Avon BS10 5NB, United Kingdom.
Aim: Routine carcino-embryonic antigen blood testing is required after colorectal cancer resection, requiring face-to-face appointments. This has workforce implications, and impacts patients' lives. We assessed feasibility and acceptability of self-taken blood tests.
View Article and Find Full Text PDFImplementation preferences for the management of sexually transmitted infections in the South African health system: a discrete choice experiment.
Sex Transm Infect
January 2024
Department of Implementation Science, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Article Synopsis
- A study investigated preferences for STI diagnosis and treatment among HIV PrEP users in South Africa, finding that most participants preferred self-sampling and same-day treatment over traditional methods.
- The research involved a survey conducted with 496 individuals aged 18-49, primarily female and under 30, analyzing their preferences using discrete choice experiments.
- Results showed two distinct groups: one with a strong preference for self-sampling and expedited partner treatment, and another group with a lower preference for self-sampling but favoring healthcare professional-initiated partner notification.
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy.
Viruses
September 2023
Department of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
In the context of cervical cancer prevention, where human papillomavirus (HPV) infection is pivotal, HPV testing is replacing Pap Smear in primary screening. This transition offers an opportunity for integrating self-sampling to enhance coverage. We evaluated the accuracy of HPV testing using self-collected urine and vaginal samples, comparing them to physician-collected cervical swabs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!